Here, we will introduce the current targeted drug therapies and immunotherapies therapies for NSCLC based on official information from the American Cancer Society.
Summarizing the current preclinical and clinical evidence about bystander effect of ADCs in solid tumors.
FDA approved 37 novel drugs IN 2022, lets find the potencial blockbusters.
So far, the need for effective therapies for COVID-19 remains high. As peoples understanding of the structure, function and pathogenic processes of the novel coronavirus has improved, many sm…
In this article, we will introduce this new star semaglutide in the hypoglycemic and weight loss field.
Antibody-drug conjugates side effects should not be ignored.